Literature DB >> 21195877

In vivo radiobiological characterization of proton beam at the National Cancer Center in Korea: effect of the Chk2 mutation.

Sang Soo Kim1, Dong Wan Choo, Dongho Shin, Hye Jung Baek, Tae Hyun Kim, Noboru Motoyama, Blanche M De Coster, John Gueulette, Yoshiya Furusawa, Koichi Ando, Kwan Ho Cho.   

Abstract

PURPOSE: The relative biological effectiveness (RBE) in the presence or absence of CHK2 was estimated at the Korean National Cancer Center Proton Therapy Center (NCCPTC). METHODS AND MATERIALS: The proton beam was fixed at 210 MeV with 6-cm spread-out Bragg peaks (SOBPs) because this is expected to be the most frequently used clinical setting. X-rays were obtained using a 6-MV conventional linear accelerator. The RBE was estimated from the survival of jejunal crypt in C3H/He and Chk2(-/-) mice.
RESULTS: The estimated RBEs of the NCCPTC at the middle of the SOBP were 1.10 and 1.05 in the presence and absence of CHK2, respectively. The doses that reduced the number of regenerated crypt per jejunal circumference to 20 (D(20)) in C3H/He mice were 14.8 Gy (95% confidence interval [CI], 13.7-15.9) for X-rays and 13.5 Gy (95% CI, 14.5-15.5) for protons. By contrast, the doses of D(20) in Chk2(-/-) mice were 15.7 Gy (95% CI, 15.0-16.4) and 14.9 Gy (95% CI, 14.0-15.8) for X-rays and protons, respectively.
CONCLUSIONS: The RBE of the NCCPTC is clearly within the range of RBEs determined at other facilities and is consistent with the generic RBE value of 1.10 for 150- to 250-MeV beams. The mutation of Chk2 gave rise to radioresistance but exhibited similar RBE. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21195877     DOI: 10.1016/j.ijrobp.2010.08.010

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  A High-Precision Method for In Vitro Proton Irradiation.

Authors:  Michelle E Howard; Janet M Denbeigh; Emily K Debrot; Nicholas B Remmes; Michael G Herman; Chris J Beltran
Journal:  Int J Part Ther       Date:  2020-10-01

2.  Basics of particle therapy II: relative biological effectiveness.

Authors:  Jinhyun Choi; Jin Oh Kang
Journal:  Radiat Oncol J       Date:  2012-03-31

3.  Enhanced radiobiological effects at the distal end of a clinical proton beam: in vitro study.

Authors:  Yoshitaka Matsumoto; Taeko Matsuura; Mami Wada; Yusuke Egashira; Teiji Nishio; Yoshiya Furusawa
Journal:  J Radiat Res       Date:  2014-05-13       Impact factor: 2.724

4.  RBE and OER within the spread-out Bragg peak for proton beam therapy: in vitro study at the Proton Medical Research Center at the University of Tsukuba.

Authors:  Ayae Kanemoto; Ryoichi Hirayama; Takashi Moritake; Yoshiya Furusawa; Lue Sun; Takeji Sakae; Akihiro Kuno; Toshiyuki Terunuma; Kiyoshi Yasuoka; Yutaro Mori; Koji Tsuboi; Hideyuki Sakurai
Journal:  J Radiat Res       Date:  2014-05-29       Impact factor: 2.724

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.